Medicare Part B premiums will rise nearly 7 percent next year to $144.60 per month, CMS officials announced.

Amgen will lay off a quarter of its staff in Cambridge, Mass., and halt all neuroscience research, according to the Boston Business Journal.

Walgreens recently bought, and then closed, seven community pharmacies in Ohio, according to The Columbus Dispatch. 

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Private equity firm KKR & Co. made a formal offer Nov. 11 to buy Walgreens Boots Alliance in what would be the largest leveraged buyout in history, people familiar with the deal told Bloomberg.

Bi-Mart, a grocery chain with stores in Oregon, Washington and Idaho, will close all its in-store pharmacies in Portland, Ore., according to Fox 12.

The FDA has authorized marketing of Vela Diagnostics' test to detect HIV Type 1 drug resistance mutations.

The FDA approved Nov. 8 Celegene's drug, Reblozyl, designed to treat anemia in adult patients with beta thalassemia who require regular red blood cell transfusions.

A federal jury in Seattle awarded a former Biogen sales representative nearly $6 million after she claimed the drugmaker fired her for refusing to pursue off-label marketing, according to STAT.

Aurobindo Pharma joined a growing list of drugmakers recalling their ranitidine products over concerns they produce a possible carcinogen.